Skip to main content
Clinical Trials/NCT04876950
NCT04876950RecruitingNot Applicable

Post Discharge After Surgery Virtual Care with Remote Automated Monitoring Technology-2 (PVC-RAM-2) Trial

Population Health Research Institute2 sites in 1 country2,000 target enrollmentStarted: October 4, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
2,000
Locations
2
Primary Endpoint
Acute-hospital care

Study Overview

Brief Summary

The Post discharge after surgery Virtual Care with Remote Automated Monitoring technology-2 (PVC-RAM-2) Trial is a multicentre, parallel group, superiority, randomized controlled trial to determine the effect of virtual care with remote automated monitoring (RAM) technology compared to standard care on acute-hospital care during the 45-day follow up after randomization, in adults who have undergone semi-urgent (e.g., oncology), urgent (e.g., hip fracture), or emergency (e.g., ruptured abdominal aortic aneurysm) surgery. Secondary outcomes at 45 days after randomization include 1) days in hospital; 2) index length of hospital stay; 3) hospital re-admission; 4) emergency department visit; 5) medication error detection; 6) medication error correction; and 7) surgical site infection. Additional secondary outcomes are pain of any severity, and moderate-to-severe pain assessed at 15 and 45 days. We will also assess optimal management of long-term health by evaluating among self-reported current smokers and those with atherosclerotic disease, whether patients are taking classes of efficacious medications at 45 days post randomization.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • are ≥40 years of age;
  • will undergo or have undergone semi-urgent, urgent, or emergency surgery requiring expected hospital stay of ≥2 days; and
  • provide informed consent to participate.

Exclusion Criteria

  • planned transfer to a rehabilitation or convalescent facility, or repatriation from trial hospital site to local community hospital following surgery;
  • are unable to communicate with research staff, complete study surveys, or undertake an interview using a tablet computer due to a language barrier or a cognitive, visual, or hearing impairment; or
  • reside in an area without cellular network coverage.

Outcomes

Primary Outcomes

Acute-hospital care

Time Frame: 45 days post randomization

Composite outcome of hospital re-admission and emergency department visit, which includes urgent-care centre visit.

Secondary Outcomes

  • Days in hospital(45 days post randomization)
  • Index length of hospital stay(45 days post randomization)
  • Hospital readmission(45 days post randomization)
  • Medication error detection(45 days post randomization)
  • Emergency department visit(45 days post randomization)
  • Moderate to severe pain(15 and 45 days post randomization)
  • Medication error correction(45 days post randomization)
  • Optimal pharmacological management for patients with atherosclerotic disease(45 days post randomization)
  • Optimal pharmacological management self-reported current smokers(45 days post randomization)
  • Surgical site infection(45 days post randomization)
  • Pain of any severity(15 and 45 days post randomization)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Post Discharge After Surgery Virtual Care... | Clinical Trial